Coverage
-
November 04, 2013
Takeda Pharmaceutical Co. Ltd. on Friday scored victories in three of its patent infringement suits in California federal court against drugmakers looking to sell a generic version of its acid reflux medicine Dexilant, convincing the court that a total of four of its patents would be infringed if the generics went to market.
1 other articles on this case.
View all »